Buy Like Buffett
Watchlist

Flagship explainer

How ADC Therapeutics SA makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$81.4M · 100%Cost of revenue$5.8M · 7%Gross profit$75.6M · 93%Operating income−$121M · −149%Income before tax−$142M · −174%Income tax$1M · 1%Net income−$143M · −175%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$81.4M100%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-016491 · filed Mar 10, 2026
Cost of revenue$5.8M7%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-016491 · filed Mar 10, 2026
$75.6M93%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-016491 · filed Mar 10, 2026
−$121M−149%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-016491 · filed Mar 10, 2026
Income before tax−$142M−174%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-016491 · filed Mar 10, 2026
Income tax$1M1%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-016491 · filed Mar 10, 2026
−$143M−175%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-016491 · filed Mar 10, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-016491 · filed Mar 10, 2026
· event Dec 31, 2025 · retrieved Oct 18, 2026 · annual-row source set
Embed this chart

View the full ADC Therapeutics SA analysis at Buy Like Buffett